Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2002
03/14/2002WO2002020760A2 Human vomeronasal receptor
03/14/2002WO2002020759A2 A non-steroidal anti-inflammatory drug activated gene with anti-tumorigenic properties
03/14/2002WO2002020758A2 Novel proteins and nucleic acids encoding same
03/14/2002WO2002020757A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/14/2002WO2002020756A2 Secretory molecules
03/14/2002WO2002020755A2 Phenol oxidizing enzyme variants
03/14/2002WO2002020754A2 Molecules for diagnostics and therapeutics
03/14/2002WO2002020752A2 Cloned cells, embryos, and avians and methods, of producing them
03/14/2002WO2002020751A2 Hyperglycosylated polypeptides
03/14/2002WO2002020750A1 Plasmid including host toxic gene and method for selecting transformant by using the plasmid
03/14/2002WO2002020749A2 Chimeric reporter system for cell surface receptor-ligand binding
03/14/2002WO2002020742A1 Use of ip3 kinases for preparing medicines for treating oxidative stress-related diseases
03/14/2002WO2002020741A1 Hydroxy-phenyl pyruvate dioxygenase fused with a signal peptide, dna sequence and use for obtaining plants containing herbicide-tolerant plants
03/14/2002WO2002020738A2 27877, a phospholipase and uses therefor
03/14/2002WO2002020737A2 Genome engineering by cell-permeable dna site-specific recombinases
03/14/2002WO2002020736A2 Proteases
03/14/2002WO2002020735A2 Enzymes having high temperature polymerase activity and methods of use thereof
03/14/2002WO2002020733A2 Genes involved in isoprenoid compound production
03/14/2002WO2002020730A2 Manganese lipoxygenase
03/14/2002WO2002020728A2 High growth methanotrophic bacterial strain methylomonas 16a
03/14/2002WO2002020726A2 Method for increasing the effectiveness of antiinfective agents
03/14/2002WO2002020725A2 Lnp, a protein involved in the initiation of mycorrhizal infection in plants
03/14/2002WO2002020724A2 Adenoviral targeting and manipulation of immune system response using targeting peptides
03/14/2002WO2002020723A2 Compositions and methods for targeting peptides in humans in vivo
03/14/2002WO2002020722A2 Methods and compositions for in vitro targeting
03/14/2002WO2002020721A2 Vectors derived from south african arbovirus no. 86
03/14/2002WO2002020718A2 Osteoclast-associated receptor
03/14/2002WO2002020717A2 Methods for simultaneous control of lignin content and composition, and cellulose content in plants
03/14/2002WO2002020716A2 Antisense modulation of phosphorylase kinase alpha 2 expression
03/14/2002WO2002020651A2 Human phermone polypeptide
03/14/2002WO2002020619A2 HUMAN ANTIBODIES AGAINST PSEUDOMONAS AERUGINOSA LPS DERIVED FROM TRANSGENIC XENOMOUSE$m(3)
03/14/2002WO2002020616A1 Hla-a2.1 binding peptides and their uses
03/14/2002WO2002020615A2 Antibody and/or chemokine constructs which bind to a chemokine receptor and their use in immunological disorders
03/14/2002WO2002020612A2 Human vomeronasal receptor-3
03/14/2002WO2002020611A1 Recombinant fusion protein for diagnosis of tsutsugamushi disease
03/14/2002WO2002020608A1 A new polypeptide- human lymph enhanced factor 42 and the polynucleotide encoding it
03/14/2002WO2002020607A1 A NEW POLYPEPTIDE-HUMAN BIPHENYL HYDROLASE-RELATED PROTEIN (Bph-rp)16.06 AND THE POLYNUCLEOTIDE ENCODING IT
03/14/2002WO2002020606A1 A new polypeptide- human hearing defect-related protein 38.39 and the polynucleotde encoding it
03/14/2002WO2002020605A1 A NEW POLYPEPTIDE-HUMAN CELL CYCLIN-E BINDING PROTEIN 1(Ceb1)113-70.07 AND THE POLYNUCLEOTIDE ENCODING IT
03/14/2002WO2002020604A1 A new polypeptide- human double-stranded rna binding protein 11 and the polynucleotide encoding it
03/14/2002WO2002020603A1 A new polypeptide- human tropomodulin 25.08 and the polynucleotide encoding it
03/14/2002WO2002020602A1 A novel peptide---human short chain dehydrogenase 9.9 and the polynucleotide coding this novel peptide
03/14/2002WO2002020601A1 A novel peptide---human cartilage connective protein 10.67 and the polynucleotide coding this novel peptide
03/14/2002WO2002020600A1 A new polypeptide- human zinc finger protein 10.45 and the polynucleotide encoding it
03/14/2002WO2002020599A1 A new polypeptide- human transcription regulation factor zfm1 isomer 19.47 and the polynucleotide encoding it
03/14/2002WO2002020598A1 Mucin
03/14/2002WO2002020597A2 Human vomeronasal receptor-5
03/14/2002WO2002020595A1 A novel polypeptide-homo zinc finger protein 18.04 and polynucleotide encoding said polypeptide
03/14/2002WO2002020594A1 A novel polypeptide-homodna topoisomerase ii-beta(top2b)29.48 and polynucleotide encoding said polypeptide
03/14/2002WO2002020593A1 A novel polypeptide - homo nucleoprotein matrix antigen 115.29 and polynucleotide encoding said polypeptide
03/14/2002WO2002020592A1 A novel polypeptide - homo mitochondria translating initiation factor 8.8 and polynucleotide encoding said polypeptide
03/14/2002WO2002020591A1 A novel polypeptide-homo complement receptor 12 and polynucleotide encoding said polypeptide
03/14/2002WO2002020590A1 A novel polypeptide-phosphoenolpyruvate-dependent sugar phosphotransferase 33 and the polynucleotide encoding said polypeptide
03/14/2002WO2002020589A1 A novel polypeptide-the human retinoblastoma binding protein 19.91 and the polynucleotide encoding said polypeptide
03/14/2002WO2002020588A1 A novel polypeptide-human transcriptional control factor zfm1 isomer 25.63 and the polynucleotide encoding said polypeptide
03/14/2002WO2002020587A1 A novel polypeptide-human nadh dehydrogenase subunit i-12.43 and the polynucleotide encoding said polypeptide
03/14/2002WO2002020586A1 A novel polypeptide-human large protein 10.23 and the polynucleotide encoding said polypeptide
03/14/2002WO2002020585A1 A novel polypeptide-homo cytokine signal inhibitory factor socs-5-29 and polynucleotide encoding said polypeptide
03/14/2002WO2002020584A1 A novel polypeptide-homo dna repair protein 10.23 and polynucleotide encoding said polypeptide
03/14/2002WO2002020583A1 A novel polypeptide-homo transcription factorlcr-f19.02 and polynucleotide encoding said polypeptide
03/14/2002WO2002020582A1 A novel polypeptide - homo neurofibroma amplified protein 9.24 and polynucleotide encoding said polypeptide
03/14/2002WO2002020581A1 A novel polypeptide-rna polymerase 11 related protein 11.33 and the polynucleotide encoding said polypeptide
03/14/2002WO2002020580A1 A novel polypeptide-human tnfr/ngfr protein 15 that contains cytochrome c structural domain and the polynucleotide encoding said polypeptide
03/14/2002WO2002020579A1 A novel polypeptide-homo acid phosphatase family protein 11 and polynucleotide encoding said polypeptide
03/14/2002WO2002020578A1 A novel polypeptide-homo mitochondria aspartate aminotransferase 37.29 and polynucleotide encoding said polypeptide
03/14/2002WO2002020577A1 A novel polypeptide-homo ribonucleotide reductase 10.49 and polynucleotide encoding said polypeptide
03/14/2002WO2002020576A1 A novel polypeptide - homo glandulae mammaria susceptibility gene encoding protein 12.32 and polynucleotide encoding said polypeptide
03/14/2002WO2002020575A1 A novel polypeptide-homo autoimmune disease-associated protein 10 and polynucleotide encoding said polypeptide
03/14/2002WO2002020572A2 Nucleotide sequences coding for the chrs gene
03/14/2002WO2002020569A2 Mammalian genes; related reagents and methods
03/14/2002WO2002020565A2 Collections of repeat proteins comprising repeat modules
03/14/2002WO2002020563A2 RECEPTOR IN THE EDb FIBRONECTIN DOMAIN
03/14/2002WO2002020562A2 Family member of inhibitor of apoptosis proteins
03/14/2002WO2002020560A1 Novel human cancer/testis antigen and gene thereof
03/14/2002WO2002020551A1 Antisense modulation of e2f transcription factor 2 expression
03/14/2002WO2002020550A1 Antisense modulation of mekk3 expression
03/14/2002WO2002020549A1 Antisense modulation of glioma-associated oncogene-1 expression
03/14/2002WO2002020548A1 Monocot seeds with increased lignan content
03/14/2002WO2002020547A1 Antisense modulation of bh3 interacting domain death agonist expression
03/14/2002WO2002020546A1 Antisense modulation of phosphorylase kinase alpha 1 expression
03/14/2002WO2002020545A1 Antisense modulation of a20 expression
03/14/2002WO2002020543A2 Synthons for oligonucleotide synthesis
03/14/2002WO2002020510A1 Acid-sensitive compounds, preparation and uses thereof
03/14/2002WO2002020179A2 Modified carbon, silicon and germanium surfaces
03/14/2002WO2002020060A1 Vp22 protein/nucleic acid aggregates, uses thereof
03/14/2002WO2002020056A2 Methods and compositions for producing a neurosalutary effect in a subject
03/14/2002WO2002020055A1 Remedies for heart failure
03/14/2002WO2002020053A1 Hla binding peptides and their uses
03/14/2002WO2002020052A1 Use of lipopeptides for immunotherapy of hiv-positive subjects
03/14/2002WO2002020051A2 Equine infectious anemia challenge model for testing vaccines, diagnostics and treatments
03/14/2002WO2002020050A2 Eiav p26 deletion vaccine and diagnostic
03/14/2002WO2002020049A2 Eiav chimeric vaccine and diagnostic
03/14/2002WO2002020045A2 Vaccine against microbial pathogens
03/14/2002WO2002020042A1 A method for inducing immunity comprising phagocytic particles and atp receptors
03/14/2002WO2002020040A1 Mimetic peptides for epitope of apolipoprotein b-100, concatemer and modified peptides thereof, and the vaccine composition comprising the same
03/14/2002WO2002020038A2 Method for down-regulating ige
03/14/2002WO2002020035A1 Hla binding peptides and their uses
03/14/2002WO2002020003A2 Use of carp inhibitors for the treatment of heart diseases
03/14/2002WO2002019968A2 Genetically engineered co-expression dna vaccines, construction methods and uses thereof
03/14/2002WO2002019966A2 Cardiac arrhythmia treatment methods
1 ... 2859 2860 2861 2862 2863 2864 2865 2866 2867 2868 2869 2870 2871 2872 2873 2874 2875 2876 2877 2878 2879 ... 4023